The Current Ratio as of September 2024 (TTM) for Adverum Biotechnologies, Inc. (ADVM) is 7.99

According to Adverum Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.99. This represents a change of 24.46% compared to the average of 6.42 of the last 4 quarters.

Adverum Biotechnologies, Inc. (ADVM) Historical Current Ratio (quarterly & annually)

How has ADVM Current Ratio performed in the past?

The mean historical Current Ratio of Adverum Biotechnologies, Inc. over the last ten years is 18.42. The current 7.99 Current Ratio has changed 4.24% with respect to the historical average. Over the past ten years (40 quarters), ADVM's Current Ratio was at its highest in in the March 2016 quarter at 44.86. The Current Ratio was at its lowest in in the June 2023 quarter at 3.31.

Adverum Biotechnologies, Inc. (ADVM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Adverum Biotechnologies, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adverum Biotechnologies, Inc. (ADVM) Average Current Ratio

How has ADVM Current Ratio performed in the past?

The current Current Ratio of Adverum Biotechnologies, Inc. (ADVM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adverum Biotechnologies, Inc. (ADVM) Current Ratio vs. Peers

How is ADVM’s Current Ratio compared to its peers?

Adverum Biotechnologies, Inc.’s Current Ratio is greater than uniQure N.V. (7.36), greater than Rocket Pharmaceuticals, Inc. (7.79), greater than Rhythm Pharmaceuticals, Inc. (6.53), less than Solid Biosciences Inc. (13.45), greater than MeiraGTx Holdings plc (2.36), greater than Aerovate Therapeutics, Inc. (6.51), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Rezolute, Inc. (11.82), less than AN2 Therapeutics, Inc. (10.61), greater than Passage Bio, Inc. (7.67), greater than Absci Corporation (6.49), less than Kezar Life Sciences, Inc. (9.58), greater than Oncternal Therapeutics, Inc. (2.89), less than Kodiak Sciences Inc. (10.59), greater than Galmed Pharmaceuticals Ltd. (6.48), greater than Affimed N.V. (2.71), greater than Mereo BioPharma Group plc (6.07), greater than Homology Medicines, Inc. (4.19), greater than Stoke Therapeutics, Inc. (6.67), greater than Atreca, Inc. (1.58), greater than TCR2 Therapeutics Inc. (2.96),

Build a custom stock screener for Adverum Biotechnologies, Inc. (ADVM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adverum Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adverum Biotechnologies, Inc. (ADVM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adverum Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.